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What effect does the spatial distribution of infected cells have on the effi-
ciency of their removal by immune cells, such as cytotoxic T lymphocytes
(CTL)? If infected cells spread in clusters, CTL may initially be slow to
locate them but subsequently kill more rapidly than in diffuse infections.
We address this question using stochastic, spatially explicit models of CTL
interacting with different patterns of infection. Rather than the effector : tar-
get ratio, we show that the relevant quantity is the ratio of a CTL’s expected
time to locate its next target (search time) to the average time it spends con-
jugated with a target that it is killing (handling time). For inefficient (slow)
CTL, when the search time is always limiting, the critical density of CTL
(that required to control 50% of infections, C*) is independent of the spatial
distribution and derives from simple mass-action kinetics. For more efficient
CTL such that handling time becomes limiting, mass-action underestimates
C*, and the more clustered an infection the greater is C*. If CTL migrate che-
motactically towards targets the converse holds—C* falls, and clustered
infections are controlled most efficiently. Real infections are likely to
spread patchily; this combined with even weak chemotaxis means that ster-
ilizing immunity may be achieved with substantially lower numbers of CTL
than standard models predict.1. Introduction
CD8þ cytotoxic T lymphocytes (CTL) are key elements of the adaptive immune
system in vertebrates and are critical in resolving or limiting many infections,
including human and simian immunodeficiency viruses (HIV/SIV) [1–4],
hepatitis C [5,6], lymphocytic choriomeningitis virus (LCMV) [7,8], influenza
[9–11] and listeria [12,13]. After encountering and recognizing an infected
cell by binding pathogen-derived peptides presented on MHC class I molecules
on the cell surface, a CTL may lyse the cell directly, or indirectly through the
recruitment of phagocytic cells [14]. CTL may also suppress an infection
through non-lytic, cytokine-mediated mechanisms [15,16].
It has recently become clear that populations of T cells (tissue-resident
memory cells, or Trm) continually survey potential sites of pathogen entry or
reactivation and are able to re-acquire effector function rapidly [17–19]. Cyto-
toxic Trm are likely to be crucial for sterilizing immunity to pathogens such
as HIV that enter through mucosal surfaces and become very difficult to control
once disseminated throughout the body. However, the local densities of CTL
needed to control a given infection are unknown. A model-guided estimate
of this quantity would be useful for establishing the feasibility of vaccines
aimed at inducing tissue-resident CTL memory—if only to assess whether
the required densities are physiologically possible.
For purely CTL-mediated control, the net growth rate of an infection is the
balance between its rate of spread among susceptible cells and the total rate at
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minimum (or critical) density of CTL required to reduce the
net growth rate of an infection to zero. One approach to
estimating C* is to use in vitro experiments to estimate the
minimum effector : target (E : T) ratio needed for suppression
of infected cell growth [20]. Another means is to begin with
measured microscopic quantities such as tissue-specific rates
of CTL movement or surveillance rates—the number of poten-
tial targets one CTL can survey per unit time. These
parameters can be inferred from intravital microscopy or
in vivo CTL killing assays, described below, and used as
inputs to dynamical models of CTL interacting with infected
cell populations. One such model, used extensively to describe
the within-host dynamics of viral infections, assumes ‘mass-
action’ kinetics in which the rate of loss of infected cells is
linear in both CTL and infected cell numbers. That is, for a
population of infected cells growing at net rate r in the absence
of CTL, and with a CTL population C killing these cells,
dI
dt
¼ rI  kCI: (1:1)
When C is expressed as a proportion of all surveyable cells,
the interpretation of the rate constant k is the mean number of
cells of all types (infected or not) that one CTL surveys per unit
time, multiplied by the probability of recognition and killing of
an infected cell following contact with it [21]. Mass-action has
been shown to describe CTL killing of melanoma cells both
in vitro and in vivo [20]. It also gives reasonable descriptions
of assays in which peptide-pulsed cells are injected intrave-
nously, migrate to the spleen and are killed by peptide-
specific resident CTL. In the studies that enumerated cell popu-
lations in spleens directly, using LCMV [22–25], polyoma virus
[26] and influenza virus [21], kwas estimated to be in the range
0.14–4 cells min21. Graw et al. [27] performed longitudinal
sampling of target cells in blood to infer the dynamics of CTL
and targets in the spleen, and estimated k to be between 8 and
35 cells per minute. The reasons underlying this two-orders-
of-magnitude spread are unclear. Differences in k may derive
from differences in CTL motility, in the spatial distribution of
CTL and targets within the spleen and so the numbers of CTL
effectively participating in clearance of targets, and in the
efficiencies of killing following conjugation [21].
Three assumptionsunderlying equation (1.1) are that (i) CTL
and the cells they survey are well mixed and that encounters of
one CTL with infected cells occur with Poisson statistics;
(ii) CTL perform undirected random walks (i.e. without prefer-
ential motion towards infected cells, referred to as chemotaxis)
and (iii) the time a CTL spends conjugated with an infected
cell, the handling time, can be neglected. The first assumption
holds when infected cells and CTL are scattered diffusely
throughout a tissue. The second is likely to be satisfied in the
splenic CTL killing assays, because levels of inflammation will
be lowwith peptide-pulsed (uninfected) targets and so substan-
tial chemotactic bias inCTLmovement seemsunlikely. The third
assumption is expected to be valid when the handling time h is
very short compared with 1/(kI), which is the expected time
taken for aCTL to locate its next infected cell, when these are pre-
sent at spatial frequency I, and/orwhenE : T is very large sovery
few CTL are expected to kill more than once in order to bring an
infection under control.
If these assumptions hold, then with knowledge of the
growth rate r and surveillance rate k, the critical CTL den-
sity is then simply C*¼ r/k. The simple mass-action modelcan be extended to explicitly include, for example, the
time taken for CTL to kill infected cells (the handling
time), the dynamics of virus epitope expression on infected
cells and the eclipse phase between infection of a cell and
virus production [28–30]. Closed-form solutions for C*
may not be available in these models, but C* can be
obtained numerically [28].
However, it is not obvious that equation (1.1) or its exten-
sions are appropriate descriptions of CTL interacting with live
replicating intercellular pathogens, for at least two reasons.
First, a mass-action model assumes that infected cells will
appear at random within an infected tissue, but pathogen
transmission from cell to cell likely occurs preferentially over
short ranges and as a consequence infections of relatively
immobile cells will tend to spread in foci (e.g. [31–33]).
Second, CTL may be attracted to areas of infection and cell
death via chemokines, breaking the assumption that CTL per-
form unbiased random walks. So using mass-action models to
describe CTL killing in such situations may lead to incorrect
estimates of critical CTL densities. Assuming we know the
microscopic quantity k, the uncontrolled pathogen growth
rate r, and the handling time h, what impact does the spatial
distribution of targets, and the degree of chemotaxis, have
on the critical density of CTL needed for immunity? Here
we use explicitly spatial stochastic simulations of infections
to address this question.2. Methods
We developed a stochastic agent-based model (ABM) represent-
ing the behaviour of CTL surveying a tissue containing a
spreading population of infected cells. The ABM was explicitly
spatial and allowed us to vary the patterns of infection spread,
track CTL-target conjugate dynamics and implement chemotaxis
of CTL towards infected cells. The simulator was written in
C/Cþþ and derived in part from the open source software
Scriptbots. It is freely available at https://github.com/udkad/
immunebots.(a) Overview of the agent-based model
The simulation is set up as a two-dimensional grid of non-
susceptible, susceptible and infected cells. In all simulations,
cells were uniformly placed in a two-dimensional matrix of
320 rows and 320 columns (total cells: 102 400). All cells were
susceptible to viral infection. The grid size corresponds to a
physical area of 3.2 mm by 3.2 mm (10 mm2) with toroidal
(wrap-around) boundary conditions. This choice of boundary
conditions mirrors a situation in which the simulated infection
site is surrounded by others with similar statistical properties.
All cell types and virions produced by infected cells are
modelled individually as agents with internal variables corre-
sponding to age, time since infection, time since last lytic
event, etc. Susceptible cells are immobile and are infected by
virions upon contact. Infected cells are also immobile, produce
virions and die due to viral cytotoxicity (half-life of approx. 1.4
days) or due to CTL lysis. CTL exhibit three different kinds of
behaviour: (i) searching for cells with a random walk (either
undirected, or with biased movement in response to chemotac-
tic cues), (ii) scanning cells upon contact or (iii) remaining in
conjugates with infected cells after scanning and while lysing
them. Virions travel in a straight line from their parent cell in
a randomly chosen direction until they are cleared (half-life of
approx. 4 h) or infect a susceptible cell. This simplified virion
movement was chosen simply as a means to generate infections
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isms of intercellular transmission. Upon contact with a
susceptible cell, the virion immediately infects the cell. At 1 s
intervals all agents are updated with information regarding
their current environment, and choose an action based on the
available actions in the current state with probabilities weighted
by the associated rate constants. CTL and virions move
unobstructed on the two-dimensional plane with positions
recorded at floating-point precision, but coarse-grained to a
scale of 1 mm for the detection of contacts. Multiple CTL can
bind unhindered to a single living target, but lysis time remains
unaffected by multiple bindings. A single CTL is assumed to be
able to kill multiple times. Rate constants and other parameters
used for the simulation are detailed in the electronic
supplementary material, table S1.
(b) Controlling the infected cell growth rate
In order to compare the ability of CTL to control different pat-
terns of infection, it was necessary to fix the uncontrolled
growth rate of infected cells. We adjusted the parameters for dif-
fuse and clustered infections to ensure that infected cell numbers
grew exponentially with rate constant r ¼ 1 d–1 in the absence of
CTL, corresponding to a doubling time of ln(2)/r ≃ 17 h. This is
roughly comparable to the very early rate of growth of SIV infec-
tion in the gut lamina propria in rhesus macaques [28,31]. Setting
the growth rate was straightforward for the case of diffuse infec-
tions, designed to mimic the spatial distribution of target cells
implicit in mass-action infection dynamics; in each short time
interval dt 1/r every infected cell had a probability rdt of
infecting a susceptible cell chosen at random, regardless of its
physical distance. Modelling the spatial dynamics of virions
was not required in this scenario. For clustered infections, the
growth rate is determined by a combination of the virion pro-
duction rate, speed and rate of clearance. To achieve a net
growth rate r ¼ 1 d21, these parameters were sampled from a
uniform distribution from ranges obtained from the literature
[34–38]. The parameter which most strongly influenced the
rate of growth was the virion production rate. This parameter
was then varied by+5% in steps of 0.005%, and each parameter
set was simulated 1000 times. The infected cell growth rate was
calculated from each simulation, and then linear regression was
used to find the virion production rate which corresponded to
an overall growth rate r ¼ 1. Parameters used for diffuse and
clustered infections are shown in the electronic supplementary
material, table S1.
(c) CTL speed and conjugate dynamics
Two parameters in the ABM govern the CTL surveillance rate
(the rate at which CTL move between surveyable cells, in the
absence of killing): CTL velocity, the straight-line distance
moved in micrometres per second; and the scan time, the
time a CTL spends stationary whilst scanning an uninfected
cell. To achieve a prescribed surveillance rate in the simulation,
100 CTL were placed among uninfected, non-susceptible cells.
Multiple simulations were run with different parameter sets.
For CTL velocity, the simulated range was 1–35 mmmin21
[39,40]. Mempel et al. [41] estimated that detachment without
lysis following an encounter with an infected cell takes
approximately 2 min. This is therefore a strong upper bound
on the scanning time. Because the majority of the in vivo pep-
tide-pulsed target killing assays give estimates of the order a
minute for the mean time spent between contacts, we used
CTL scanning times of between 1 and 15 s cell21. Achieving
such a rate of surveillance of the order 1 min required rela-
tively fast-moving CTL with short scan times. We used a
velocity of 7.5 mmmin21 and a scan time of 5 s, which trans-
lated to a CTL surveillance rate of 1.1 cells min21. To studythe control of infections at high E : T or search to handling
time (S:H) ratios, CTL speed was reduced to 0.18 mmmin21,
which translated to a CTL surveillance rate of 0.022 cells min21.
Finally, CTL may remain attached to infected cells for tens of
minutes [41,42]; in our simulations we used a handling time
of 30 min.(d) Modelling CTL chemotaxis
Chemotaxis was implemented as follows. Every time the CTL
moves in a new direction, the new direction angle is chosen
either at random from the directions +458 or the direction of
the nearest infected cell. This choice occurs when a CTL comes
to the end of a persistent segment of its motion (default length
of 25 mm), finishes scanning an uninfected cell or lyses an infected
cell. Note that although CTL motion has a persistence length, the
high density of cells means that a CTL ‘step’ is almost always
interrupted by a scan event. The strength of chemotaxis was deter-
mined by the frequency of non-random movements. Frequencies
used in the simulations were 0% (no chemotaxis), 1%, 5% and
20%. CTL under directed motion are attracted to the nearest
living target, which included CTL-target conjugates. Varying
levels of chemotaxis did not influence the cell speed, such that
the surveillance rate k remained constant.(e) Estimating the critical CTL density C*
In the deterministic case, C* is the CTL density required to reduce
the growth rate of the infection to zero. In the stochastic case, we
define C* as the density of CTL (as a fraction of all scannable
cells) required to drive the virus extinct in 50% of simulations.
For a given C, our estimate of the probability of extinction was
the proportion of 200 simulations in which the infected cell
count fell to zero. Where a clear determination was not possible,
for example when the infected cell frequency fluctuated near
zero, the outcome was determined by the gradient of the time
course of infected cell numbers over the last 12 h of the
simulation—negative implies eventual extinction, positive
implies a successful infection. We used a simple adaptive
search algorithm to identify C* given broadly spaced initial
guesses. The dependence of the probability of extinction on C
was well described with a sigmoid function
Pextinct(C) ¼ 11þ ea(CC) : (2:1)
The above equation was then used to estimate the free
parameters C* and the steepness parameter a, using the
Nelder–Mead algorithm in the FME package in R [43].3. Results
(a) The agent-based model recapitulates deterministic
mass-action models when targets are spread
diffusely
We wanted to assess the effect of spatial structure of infected
cell populations on the ability of CTL to control infections.
The critical CTL density C* predicted by the simplest canoni-
cal ordinary differential equation (ODE) model might be used
as a first guess of the CTL required and serves as a reference
point. With this in mind, we performed a calibration process
to ensure that the average dynamics predicted by the stochas-
tic ABM simulations of diffuse infections (see Methods), in
which CTL and infected cells are well mixed, agreed with
those predicted by simple mass-action models.
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Figure 1. Kinetics of infected cells spreading diffusely and being killed by CTL. Infected cells (vertical axes, logarithmic scale) were seeded in the simulation and
allowed to grow to 1000 cells, appearing at random within the tissue, before CTL were introduced randomly among them, at a time denoted day 0. We varied the
ratio of CTL to effector cells at day 0 (horizontally) and the ratio of search time to handling time (vertically) to explore the ability of the simple mass-action (dashed
blue line) and extended mass-action (dotted red line) ODE models to explain the simulated data. Note how the extended model better fits the data when the
handling time is greater than the search time (lower left and lower centre figures).
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models. The first is the simplest mass-action model (equation
(1.1)) describing CTL killing of target cells T replicating at
uncontrolled rate r
dI
dt
¼ rI  kCI, ¼)I(t) ¼ I(0) exp ((r kC)t), (3:1)
where I and C are expressed as dimensionless quantities in
the range [0,1]. Recall that we assume 100% efficiency of
killing of targets following contact k is the surveillance rate,
such that 1/k is the mean time for a CTL to move between
one cell of any kind and the next; and 1/(kI) is the search
time, or the expected time for a CTL to locate an infected
cell. The critical CTL density is then C* ¼ r/k; in this
model, densities greater than this guarantee eventual
clearance of the infection.
The second we call the extended mass-action model.
Upon recognition of an infected cell, CTL may remain
attached for tens of minutes [41,42]. An appropriate determi-
nistic model that includes this process is an age-structured
partial differential equation that follows the population den-
sity of CTL and infected cells that have been conjugated for a
time t, X(t,t)
dC(t)
dt
¼ kC(t)T(t)þ X(t, h), (3:2)
@X(t, t)
@t
þ @X(t, t)
@t
¼ 0, where X(t, 0) ¼ kC(t)T(t) (3:3)
and
dT(t)
dt
¼ rT(t) kC(t)T(t): (3:4)
The extended mass-action model reduces to the simpler
model when CTL are in excess (high E : T, or equivalently
C0 T(0)) and/or when handling times are short comparedwith search times, h 1/(kT), such that the age structure in
equation (3.3) can be neglected [28].
To perform the comparisons, we prescribed the handling
time (h ¼ 30 min), the infected cell growth rate in the absence
of CTL (r ¼ 1 d–1), the time taken to scan an uninfected cell
(which was assumed to be negligible and not considered in
either deterministic model) and the surveillance rate (k) as
inputs to the ABM. The infected cell population was allowed
to grow to a size of 1000 cells distributed across a grid of 105
cells in total before CTL were introduced spatially at random
at known densities C. We simulated conjugates persisting for
a fixed handling time h ¼ 30 min.
We found close agreement between the mean timecourse
of diffuse infection simulations and the extended mass-action
model, for all parameter regions (figure 1). As expected, the
simple mass-action model held at high S : H and/or high E :
T but broke down when both conditions were violated. How-
ever, given noise in experimental data, apparently mass-action
dynamics (linear decay of infected cells on log scale) might
superficially appear to hold at low E : T (figure 1, left hand
column), as has been observed experimentally [25].(b) The influence of the spatial distribution of targets
on efficiency of CTL control
Next we wanted to assess the impact of breaking the assump-
tions of the simple mass-action model on critical CTL
densities. We began by preserving the assumption that CTL
perform undirected random walks, and compared their abil-
ity to control two modes of pathogen spread: one in which
infected cells appear randomly and are uniformly distributed
across the tissue, and a clustered model in which infection
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seeded with a single infected cell and the infection was
allowed to grow to different cell numbers IC before introdu-
cing CTL distributed at random across the tissue. For each
value of IC, we performed repeated simulations with different
numbers of CTL (C ) to estimate the probability of extinction
as a function of C. As described in Methods, the critical
density C* was the value of C at which 50% of infections
eventually went extinct.
We used two values of the surveillance rate, k, in order to
explore a wide range of S : H and E : T ratios without compu-
tational expense becoming prohibitive at large numbers
of infected cells. Control at high S : H was explored using
k ≃ 0.02, substantially lower than the values estimated in
in vivo killing assays. However, the parameter k is implicitly
the product of the surveillance rate and the probability of
recognizing a cell as being infected and initiating lysis, so
this value of k may correspond to inefficient (or perhaps
exhausted) CTL. Control at low E : T was explored with k ≃
0.7, a value derived from in vivo measurements of CTL vel-
ocities and which is in line with the estimates from splenic
killing assays. Critical CTL densities were expressed in units
of the basic mass-action estimate C* ¼ r/k, which allowed us
to compare the fold-changes in critical CTL densities for differ-
ent spatial distributions of targets across different values of k.
(i) When search times are much longer than handling times, the
spatial distribution of targets has little impact on the
efficiency of CTL, and mass-action provides good
estimates of C*
At the low surveillance rate k ≃ 0.02, C* for diffuse infections
was close to the mass-action prediction (C* ≃ r/k, or relative
C* ≃ 1) for initial infected population sizes of between 250
and 4000, corresponding to CTL appearing between 5.5 and
8.3 days post infection (figure 2a–e, blue curves). The stochas-
ticity in infection dynamics in this model is reflected in the
sigmoid shape of these curves—extinction is possible even
for CTL densities below the critical level predicted by the
deterministic model.
Strikingly, at this low surveillance rate we found that
breaking the well-mixed assumption and allowing infections
to be clustered had very little impact on extinction probabil-
ities (figure 2a–e, orange curves) with departures only
becoming apparent when E : T fell below 1 (figure 2e).
This insensitivity to spatial structure derives from the
ratio of search to handling times. Recall that mass-action is
expected to hold when the E : T ratio is high and/or the
mean time for a CTL to locate its next target, 1/kI, is greater
than the handling time h. For diffuse infections, even up to
day 8 when 4000 cells are infected out of 105 potential targets
(figure 2e), the search time 1/kI ≃ 830 min is much longer
than the handling time, and so we predict and observe
simple mass-action kinetics with C*¼ r/k, even if E : T falls
below 1 (figure 2a–e, blue curves). Second, if this low level
of k reflects low motility rather than low detection efficiency,
control of clustered infections is likely mediated predomi-
nantly by CTL resident in or near foci of infection. Even
within a large densely packed cluster in which 100% of
cells are infected, at this low k the mean search time is still
1/k ≃ 50 min, compared to a handling time of 30 min. If
CTL and targets within a cluster are well mixed, then if hand-
ling time is comparable to search time, simple mass-action isexpected to hold asymptotically [28], giving C* ≃ r/k (figure
2a–e, orange curves).
We conclude that when CTL perform undirected random
walks and are relatively inefficient such that the mean time to
move between infected cells is greater than or of the order of
the handling time, even within foci of infection, the spatial
distribution of targets has little impact on C* and it lies
close to the simple mass-action prediction.(ii) With undirected CTL motion, when CTL are sufficiently motile
that handling time becomes limiting, clustered infections are
more difficult to control than diffuse infections
For more rapid surveillance, in diffuse infections C* is given
by mass-action and is independent of I0, while S : H 1.
Mass-action eventually breaks down when CTL appear so
late that infected cell densities are high and the search time
approaches the handling time (figure 2f– j, blue curves).
The search time 1/kI0 (I0 expressed as a proportion of all sur-
veyable cells) is approximately 140 min at I0 ¼ 1000, 70 min at
I0 ¼ 2000 and 35 min at Ic ¼ 4000, compared to the handling
time of 30 min. At this point, handling time begins to be lim-
iting and C* starts to increase with the infected cell count
(figure 2h–j, blue curves).
For very motile CTL and clustered infections, within foci
the search time is very short ( 1/k ≃ 90 s) and is much less
than the handling time. At low-infected cell numbers, at C*
few CTL are required to kill more than once to bring the
infection under control and the limiting effect of handling
time is only weakly apparent (figure 2f ). However, the low
S : H ratio within clusters means that handling time becomes
limiting at lower infected cell numbers than in the diffuse
case (figure 2g–j, orange curves).
Thus, when CTL move with undirected random walks and
are relatively efficient such that the time taken to move between
adjacent cells is shorter than the handling time, the spatial distri-
bution of infected cells can have a substantial impact on critical
CTL densities. Clustered infections require more CTL to control
than a diffuse infection growing at the same rate, and become
progressively harder to control the later CTL arrive.(c) CTL chemotaxis reduces C* and the degree of
chemotaxis influences the effect of spatial structure
on the efficiency of clearance
Next we broke another implicit assumption of mass-action
models and allowed different degrees of chemoattraction of
CTL towards their targets. As described in Methods, this was
done by assigning different probabilities that, at each turning
event, a CTL moves in the direction of the nearest infected
cell. This is a rather extreme implementation of chemotaxis
that imposes no range on the influence of chemokine gradients,
and so the probability of a turn being directed was limited to
20% at most. Unsurprisingly, chemotaxis reduces the number
of CTL required for control in general (figure 3). This can be
understood as an effective increase in the surveillance rate k.
For all degrees of chemotactic attraction, the earlier CTL
appear the more substantial the reduction in C* relative to
undirected searches. This is because the sparser the targets
are, the bigger is the fractional reduction in search timeprovided
by directed motion towards infected cells.
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Figure 2. Probabilities of extinction as a function of CTL density in units of the mass-action estimate C*¼ r/k. (a–e) Slow CTL surveillance such that S : H . 1
even within packed clusters of infected cells; ( f– j) more rapid CTL migration, such that S : H , 1 within clusters. Blue curves, diffuse infections; orange curves,
clustered infections. S : H ratios are approximate and calculated as follows: for diffuse infections, S is the expected time for a CTL to locate its first target following
the appearance of CTL when infected cell numbers have reached I0, S ≃ N/kI0, where I0/N is the proportion of all susceptible cells infected. For clustered infections,
the search time is quoted as the time taken to move between adjacent cells within a packed cluster of infected cells, and so is a strong lower bound on the average
search time. E : T ratios are quoted as the ratio of total effectors to total targets at the critical CTL density C*. PI, post-infection.
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undirected motion, C* is insensitive to the spatial distri-
bution of the infection for all levels of chemotaxis (blue
and orange points lie close together). For both clustered
and diffuse infections, S : H. 1 for inefficient CTL (the
shortest search time between infected cells is 80 min evenwith highly directed motion, compared to a handling time
of 30 min).
At higher surveillance rates (figure 3e–h), we see more
complex behaviour that arises from the interplay between
the positive effect of chemotaxis and the sequestration of
CTL in conjugates that limits the killing rate. In general, we
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Figure 3. Critical CTL densities (in units of the basic mass-action estimate C*¼ r/k) for different levels of chemotaxis. (a–d) Slow CTL surveillance and (e–h) rapid
surveillance. Blue triangles, diffuse infection; orange circles, clustered infection. Note logarithmic scale on y-axes.
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taxis render clustered infections easier to control (figure 3f–g,
left-hand points) but that differences in C* due to spatial
structure shrink again as CTL motion becomes highly
directed (figure 3h). Again, these results can be understood
intuitively. Early in clustered infections, a directed searchstrategy substantially reduces the time for each CTL to
locate a cluster. Subsequent location of infected cells is
rapid and limited only by handling time. By contrast, early
in diffuse infections the mean time for a randomly chosen
CTL to locate its first target may be shorter than for a focal
infection, but the identification of subsequent targets requires
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taxis is then that small focal infections are easier to control
(figure 3f–g, left-hand points). However, at higher densities
of infected cells (i.e. if CTL appear later) the time to locate
the next target in either scenario becomes dominated by the
handling time. Spatial structure then becomes less important
(figure 3f–g, right-hand points). Finally, when migration is
highly directed (figure 3h), the search time is small compared
with handling time at all infected cell densities and for all
spatial distributions, and so again the critical CTL densities
for diffuse and clustered infections converge (figure 3h). As
above, the fold reduction in C* is greatest the earlier CTL
appear, because the fold increase in the search time is greatest
when targets are sparse.
In summary, in this modelling framework (i) highly
directed motion is an optimal search strategy for all patterns
of infection; (ii) with any level of directed motion, the earlier
CTL arrive at the site the fewer are required to clear the infec-
tion; (iii) in general, at weak to moderate levels of chemotaxis,
the more clustered an infection the easier it is to control; and
(iv) at very high levels of chemotaxis, such that locating
targets is very efficient and handling time is limiting, the
efficiency of clearance becomes insensitive to the spatial dis-
tribution of targets.4. Discussion
The E : T ratio is typically considered the quantity of interest
for the control of infections, but when considering the impact
of spatial structure, we found that a key parameter was
instead the ratio of the expected time to detect the next
target (the search time) to the handling time, or S : H. Surpris-
ingly, when CTL are inefficient in finding targets even within
clusters (i.e. when S : H. 1) we found that the spatial distri-
bution of targets has minimal impact on critical CTL
densities. In this case, the simple mass-action prediction
C* ¼ r/k derived from microscopic parameters applies.
When CTL are able to locate targets rapidly enough that
handling time becomes limiting, we found (perhaps surpris-
ingly) that the more clustered an infection the more CTL are
needed for control. Chemotaxis towards infected cells
decreased the critical density of CTL, most dramatically
when CTL appear early in infections. Weak chemotaxis
reversed the trend observed in undirected walks, and the
more clustered an infection the fewer CTL are needed to con-
trol it. Finally, strongly directed motion towards infected cells
renders the efficiency of control insensitive to the spatial
structure of an infection.
Clearly, strongly directed motion is an optimal strategy for
locating a given target rapidly. Neutrophils have been seen to
flock rapidly towards foci of infection (see, e.g. [44] and refer-
ences therein); Kastenmuller et al. [45] found strong evidence of
chemokine-driven motion of CTL towards infection sites
within the subcapsular sinus of a lymph node; and chemo-
kines have been shown to drive the attraction of CTL, at
least broadly, to tumour masses [46,47]. There is also evidence
that the gp120 HIV envelope glycoprotein mediates chemoat-
traction of CTL via the CXCR4 chemokine receptor at low
concentrations but there is repulsion at higher concentrations
in vitro, potentially inhibiting CTL activity [48]. However to
our knowledge, only two studies have directly quantified the
statistics, and in particular the directedness, of effector CTLmovement within an infected tissue in vivo. Harris et al. [49]
described CTL motion as a Le´vy flight, with persistent seg-
ments of lengths drawn from a heavy-tailed distribution,
linked by turns through uniformly distributed angles. They
observed an increase in CTL speed in the presence of infection
but with random walk statistics unchanged (a phenomenon
known as orthotaxis). However, the spatial distribution of tar-
gets was not characterized, and if CTL and targets are well
mixed it may be difficult to detect a signature of directed
motion on small scales using multiphoton imaging, particu-
larly if it is weak [50–53]. Kelemen et al. [54] compared the
trajectories of antigen-specific and non-specific T cells in the
livers of mice infected with sporozoites of the malaria parasite
and showed a propensity for cells of both types to move
towards infected cells at distances up to 140 mm, or roughly
six to seven hepatocyte widths. Interestingly, they saw a
small but significant increase in the degree of attraction of
antigen-specific over non-specific cells over distances of
40–140 mm but no difference in degrees of attraction at shorter
distances. Again, this may be due to difficulties in detecting
directed motion over such short length scales.
Much of our understanding of T-cell movement patterns
comes from studies of naive T cells in lymph nodes, in the
presence and absence of cognate antigen on dendritic cells
(DC). Chemokines have been shown to attract naive CD8þ
T cells towards DC [55–58], but other analyses have found
little evidence for directed motion in the presence of antigen
[39,59,60] and found that on small scales T cells perform per-
sistent random walks, i.e. linear motion on short scales
punctuated by turns through uniformly distributed angles.
Again, though, directed motion may be undetectable if anti-
gen-presenting cells are present at a high density and
diffusely spread within a lymph node. It has been suggested
that an undirected random walk is an optimal search strategy
for naive T cells in the presence of cognate antigen [39,61],
and a cellular automata model has been used to argue that
directed motion may increase the occlusion of DC by non-
specific T cells and hinder the efficiency of recruitment of
antigen-specific cells into a response [62]. More recently how-
ever, a model of migration using cells with deformable
membranes (the Cellular Potts Model) was used to argue
the converse, showing that weak chemotaxis may indeed
facilitate repertoire scanning [53].
Our analyses are most relevant for infections of relatively
static cell populations in planar environments, such as layers
of epithelial cells, interacting with an initially scattered
population of CTL such as tissue-resident memory cells.
Significant target motility will generate more diffuse patterns
of pathogen spread and so will make the simple mass-action
estimate more appropriate. We speculate that in three dimen-
sions the search time is more likely to be limiting and so the
simple mass-action estimate of C* may again be more appro-
priate, at least for the case of unbiased random walks. A
plausibility argument is that the probability of locating a
given target a finite distance away from a CTL is roughly
equivalent to the drunkard’s walk problem, in which one
estimates the probability that a random walk will eventually
return to its starting point. For random walks with constant
step length, the probability of eventual return to the vicinity
of the origin is 1 in two dimensions, but only approximately
0.34 in three dimensions [63].
In summary, our study shows that the average search time
and the handling time are the key indicators of whether spatial
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critical CTL densities. In particular, we found that in the
absence of chemotaxis and when handling time is not limiting,
the mass-action estimate of C* applies, irrespective of spatial
structure. This also illustrates that the inverse problem of infer-
ring spatial structure from the kinetics of clearance is not well
defined—the accuracy of the mass-action estimate of C* does
not imply spatial homogeneity, and conversely, spatial hetero-
geneity does not imply that the mass-action estimate of C* is
incorrect. Further, our simulations confirm the intuitive result
that chemotactic motion of initially scattered CTL towards
their targets appears to be an optimal strategy. What is striking
is that, at least in planar environments, even weak chemotaxis
can improve the efficiency of control markedly, and most nota-
bly for infections that are clustered. For example, with plausible
parameters for CTL motility and the infection growth rate, a
1% probability that the next turn is directed towards an
infected cell has the potential to reduce critical CTL numbers
roughly threefold over the simple estimates early in infection(figure 3f ). Since it seems clustering of infected cell popu-
lations is the norm, and that it is likely that CTL experience
at least some degree of chemoattraction towards foci of infec-
tion, then our simulations suggest that a simple mass-action
model derived from two microscopic parameters (uncontrolled
pathogen growth rate and CTL surveillance rate) yields an
upper bound on critical CTL densities; combined with
orthotaxis and non-lytic modes of pathogen suppression, infec-
tions may be controlled with lower numbers of tissue-resident
CTL than predicted with simple models.
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